
DOI . ORG {
}
Title[redir]:
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients | Breast Cancer Research and Treatment
Description:
Currently used methods to detect and enumerate circulating tumor cells (CTCs) rely on the expression of the epithelial cell adhesion molecule (EpCAM) and cytokeratins. This selection may exclude cells that have undergone intrinsic modifications of their phenotype, as epithelial-mesenchymal transition (EMT). Aim of the study was to investigate the expression of EMT and stemness markers in CTCs from breast cancer patients in all stages of disease. 92 female breast cancer patients were enrolled. CTCs were isolated by CELLection™ Dynabeads® coated with the monoclonal antibody toward EpCam. Samples found positive for CTCs presence (CD45−/CK+) were evaluated for the expression of ER alpha, HER2, ALDH1, vimentin, and fibronectin. Samples negative for CTCs presence (CD45−/CK−) were also evaluated for the expression of vimentin and fibronectin, used as markers of EMT. CTCs were found in 66% of patients. The distribution of CTCs presence according to stage and grade of disease was found statistically significant. The expression of ALDH1 on CTCs was found to correlate to stage of disease and to the expression of vimentin and fibronectin. In 34% of patients, we detected cells with negative CK/CD45 expression but positive expression of vimentin and fibronectin. There is an urgent need for optimizing CTCs detection methods through the inclusion of EMT markers. The detection of cells in mesenchymal transition, retaining EMT and stemness features, may contribute to discover additional therapeutic targets useful to eradicate micrometastatic disease in breast cancer.
Matching Content Categories {📚}
- Health & Fitness
- Science
- Education
Content Management System {📝}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of doi.org audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 8,426,336 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {💸}
We don't see any clear sign of profit-making.
Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Doi.org has a revenue plan, but it's either invisible or we haven't found it.
Keywords {🔍}
cancer, article, cells, breast, google, scholar, pubmed, cas, circulating, tumor, transition, patients, ctcs, expression, epithelialmesenchymal, stem, cell, emt, disease, detection, access, res, rome, research, mesenchymal, privacy, cookies, content, stemness, gazzaniga, epithelial, publish, search, study, raimondi, gradilone, naso, cortesi, epcam, markers, found, vimentin, fibronectin, discover, metastatic, open, molecular, cristofanilli, clinical, pantel,
Topics {✒️}
cancer stem cells month download article/chapter stem cell signaling epithelial–mesenchymal transition markers epithelial-mesenchymal transition epithelial mesenchymal transition node-positive breast cancer disseminated tumor cells circulating tumor cells metastatic breast cancer circulating cancer cells high ep-cam expression negative ck/cd45 expression disseminating tumour cells full article pdf related subjects mesenchymal transition privacy choices/manage cookies circulating tumour cell breast cancer patients human breast cancer eribulin-based treatment article raimondi paola gazzaniga check access instant access cancer research 69 european economic area undergone intrinsic modifications cellection™ dynabeads® coated hayes df specific biological properties international expert consensus chemosensitivity profile assay conditions privacy policy mesenchymal transitions meeting abstract supplement campus biomedico university electronic supplementary material exclude cells detected cells samples negative accepting optional cookies samples found positive found statistically significant bone marrow micrometastasis article log breast cancer eradicate micrometastatic disease journal finder publish
Schema {🗺️}
WebPage:
mainEntity:
headline:Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
description:Currently used methods to detect and enumerate circulating tumor cells (CTCs) rely on the expression of the epithelial cell adhesion molecule (EpCAM) and cytokeratins. This selection may exclude cells that have undergone intrinsic modifications of their phenotype, as epithelial-mesenchymal transition (EMT). Aim of the study was to investigate the expression of EMT and stemness markers in CTCs from breast cancer patients in all stages of disease. 92 female breast cancer patients were enrolled. CTCs were isolated by CELLection™ Dynabeads® coated with the monoclonal antibody toward EpCam. Samples found positive for CTCs presence (CD45−/CK+) were evaluated for the expression of ER alpha, HER2, ALDH1, vimentin, and fibronectin. Samples negative for CTCs presence (CD45−/CK−) were also evaluated for the expression of vimentin and fibronectin, used as markers of EMT. CTCs were found in 66% of patients. The distribution of CTCs presence according to stage and grade of disease was found statistically significant. The expression of ALDH1 on CTCs was found to correlate to stage of disease and to the expression of vimentin and fibronectin. In 34% of patients, we detected cells with negative CK/CD45 expression but positive expression of vimentin and fibronectin. There is an urgent need for optimizing CTCs detection methods through the inclusion of EMT markers. The detection of cells in mesenchymal transition, retaining EMT and stemness features, may contribute to discover additional therapeutic targets useful to eradicate micrometastatic disease in breast cancer.
datePublished:2011-02-05T00:00:00Z
dateModified:2011-02-05T00:00:00Z
pageStart:449
pageEnd:455
sameAs:https://doi.org/10.1007/s10549-011-1373-x
keywords:
Circulating tumor cells
Epithelial-mesenchymal transition
Cancer stem cells
Cytokeratins
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1373-x/MediaObjects/10549_2011_1373_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1373-x/MediaObjects/10549_2011_1373_Fig2_HTML.gif
isPartOf:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:130
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Cristina Raimondi
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Angela Gradilone
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Giuseppe Naso
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Bruno Vincenzi
affiliation:
name:Campus Biomedico University of Rome
address:
name:Division of Medical Oncology, Campus Biomedico University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Arianna Petracca
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Chiara Nicolazzo
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Antonella Palazzo
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Rosa Saltarelli
affiliation:
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Franco Spremberg
affiliation:
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Enrico Cortesi
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Paola Gazzaniga
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
description:Currently used methods to detect and enumerate circulating tumor cells (CTCs) rely on the expression of the epithelial cell adhesion molecule (EpCAM) and cytokeratins. This selection may exclude cells that have undergone intrinsic modifications of their phenotype, as epithelial-mesenchymal transition (EMT). Aim of the study was to investigate the expression of EMT and stemness markers in CTCs from breast cancer patients in all stages of disease. 92 female breast cancer patients were enrolled. CTCs were isolated by CELLection™ Dynabeads® coated with the monoclonal antibody toward EpCam. Samples found positive for CTCs presence (CD45−/CK+) were evaluated for the expression of ER alpha, HER2, ALDH1, vimentin, and fibronectin. Samples negative for CTCs presence (CD45−/CK−) were also evaluated for the expression of vimentin and fibronectin, used as markers of EMT. CTCs were found in 66% of patients. The distribution of CTCs presence according to stage and grade of disease was found statistically significant. The expression of ALDH1 on CTCs was found to correlate to stage of disease and to the expression of vimentin and fibronectin. In 34% of patients, we detected cells with negative CK/CD45 expression but positive expression of vimentin and fibronectin. There is an urgent need for optimizing CTCs detection methods through the inclusion of EMT markers. The detection of cells in mesenchymal transition, retaining EMT and stemness features, may contribute to discover additional therapeutic targets useful to eradicate micrometastatic disease in breast cancer.
datePublished:2011-02-05T00:00:00Z
dateModified:2011-02-05T00:00:00Z
pageStart:449
pageEnd:455
sameAs:https://doi.org/10.1007/s10549-011-1373-x
keywords:
Circulating tumor cells
Epithelial-mesenchymal transition
Cancer stem cells
Cytokeratins
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1373-x/MediaObjects/10549_2011_1373_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1373-x/MediaObjects/10549_2011_1373_Fig2_HTML.gif
isPartOf:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:130
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Cristina Raimondi
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Angela Gradilone
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Giuseppe Naso
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Bruno Vincenzi
affiliation:
name:Campus Biomedico University of Rome
address:
name:Division of Medical Oncology, Campus Biomedico University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Arianna Petracca
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Chiara Nicolazzo
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Antonella Palazzo
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Rosa Saltarelli
affiliation:
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Franco Spremberg
affiliation:
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Enrico Cortesi
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Paola Gazzaniga
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:130
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Campus Biomedico University of Rome
address:
name:Division of Medical Oncology, Campus Biomedico University of Rome, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Cristina Raimondi
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Angela Gradilone
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Giuseppe Naso
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Bruno Vincenzi
affiliation:
name:Campus Biomedico University of Rome
address:
name:Division of Medical Oncology, Campus Biomedico University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Arianna Petracca
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Chiara Nicolazzo
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Antonella Palazzo
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Rosa Saltarelli
affiliation:
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
type:Organization
name:Franco Spremberg
affiliation:
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
type:Organization
name:Enrico Cortesi
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Paola Gazzaniga
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
name:Division of Medical Oncology, Campus Biomedico University of Rome, Rome, Italy
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(162)
- What's the revenue for https://link.springer.com/privacystatement?
- How much income does https://link.springer.com/article/10.1007/s10549-011-1373-x/#main have?
- What's the income generated by https://link.springer.com each month?
- How much does https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s10549-011-1373-x earn?
- Profit of https://link.springer.com/article/10.1007/s10549-011-1373-x/#eds-c-header-nav
- Revenue of https://link.springer.com/journals/
- What's the profit of https://www.springernature.com/gp/authors?
- How much does https://link.springernature.com/home/ rake in every month?
- How much does https://link.springer.com/article/10.1007/s10549-011-1373-x/#eds-c-header-popup-search rake in every month?
- What's https://order.springer.com/public/cart's gross income?
- What's https://link.springer.com/article/10.1007/s10549-011-1373-x/'s gross income?
- Check the income stats for https://link.springer.com/article/10.1007/s10549-011-1373-x/journal/10549
- How much revenue does https://link.springer.com/article/10.1007/s10549-011-1373-x/#citeas produce monthly?
- See how much https://link.springer.com/article/10.1007/s10549-011-1373-x/journal/10549/aims-and-scope makes per month
- How much cash flow does https://submission.springernature.com/new-submission/10549/3 have monthly?
- How much money does https://link.springer.com/article/10.1007/s10549-011-1373-x/#auth-Cristina-Raimondi-Aff1 make?
- Check the income stats for https://link.springer.com/article/10.1007/s10549-011-1373-x/#Aff1
- Financial intake of https://link.springer.com/article/10.1007/s10549-011-1373-x/#auth-Angela-Gradilone-Aff2
- How much money does https://link.springer.com/article/10.1007/s10549-011-1373-x/#Aff2 make?
- How much income does https://link.springer.com/article/10.1007/s10549-011-1373-x/#auth-Giuseppe-Naso-Aff1 have?
- How much does https://link.springer.com/article/10.1007/s10549-011-1373-x/#auth-Bruno-Vincenzi-Aff3 rake in every month?
- What's the income generated by https://link.springer.com/article/10.1007/s10549-011-1373-x/#Aff3 each month?
- How much money does https://link.springer.com/article/10.1007/s10549-011-1373-x/#auth-Arianna-Petracca-Aff2 generate?
- https://link.springer.com/article/10.1007/s10549-011-1373-x/#auth-Chiara-Nicolazzo-Aff2's total income per month
- See how much https://link.springer.com/article/10.1007/s10549-011-1373-x/#auth-Antonella-Palazzo-Aff1 makes per month
- What's the profit of https://link.springer.com/article/10.1007/s10549-011-1373-x/#auth-Rosa-Saltarelli-Aff4?
- How much does https://link.springer.com/article/10.1007/s10549-011-1373-x/#Aff4 rake in every month?
- How much money does https://link.springer.com/article/10.1007/s10549-011-1373-x/#auth-Franco-Spremberg-Aff4 generate?
- Find out how much https://link.springer.com/article/10.1007/s10549-011-1373-x/#auth-Enrico-Cortesi-Aff1 earns monthly
- Revenue of https://link.springer.com/article/10.1007/s10549-011-1373-x/#auth-Paola-Gazzaniga-Aff2
- How much revenue does https://link.springer.com/article/10.1007/s10549-011-1373-x/article/10.1007/s10549-011-1373-x/metrics generate?
- What's the financial outcome of https://wayf.springernature.com?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs10549-011-1373-x?
- See how much https://link.springer.com/product/springer-plus makes per month
- Revenue of https://www.springernature.com/gp/librarians/licensing/agc/journals
- Discover the revenue of https://link.springer.com/10.1186/s40880-018-0346-4?fromPaywallRec=true
- Monthly income for https://link.springer.com/10.1186/s13046-022-02259-8?fromPaywallRec=true
- How much does https://link.springer.com/10.1186/s12967-018-1663-8?fromPaywallRec=true gross monthly?
- How much revenue does https://link.springer.com/article/10.1007/s10549-011-1373-x/subjects/cancer-stem-cells produce monthly?
- How much income is https://link.springer.com/article/10.1007/s10549-011-1373-x/subjects/epithelial-mesenchymal-transition earning monthly?
- What's the revenue for https://link.springer.com/article/10.1007/s10549-011-1373-x/subjects/mammary-stem-cells?
- Get to know https://link.springer.com/article/10.1007/s10549-011-1373-x/subjects/mesenchymal-stem-cells's earnings
- Monthly income for https://link.springer.com/article/10.1007/s10549-011-1373-x/subjects/mesenchymal-migration
- What's the financial gain of https://link.springer.com/article/10.1007/s10549-011-1373-x/subjects/totipotent-stem-cells?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15317891?
- What's the financial gain of https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BD2cXntVeitb4%3D?
- How much does http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%2C%20disease%20progression%2C%20and%20survival%20in%20metastatic%20breast%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa040766&volume=351&pages=781-791&publication_year=2004&author=Cristofanilli%2CM&author=Budd%2CGT&author=Ellis%2CMJ&author=Stopeck%2CA&author=Matera%2CJ&author=Miller%2CMC&author=Reuben%2CJM&author=Doyle%2CGV&author=Allard%2CWJ&author=Terstappen%2CLW&author=Hayes%2CDF rake in every month?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19410375 each month?
- How much does https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BD1MXptlSks70%3D pull in monthly?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%20%28CTCs%29%3A%20detection%20methods%20and%20their%20clinical%20relevance%20in%20breast%20cancer&journal=Cancer%20Treat%20Rev&doi=10.1016%2Fj.ctrv.2009.03.004&volume=35&pages=463-474&publication_year=2009&author=Mostert%2CB&author=Sleijfer%2CS&author=Foekens%2CJ&author=Gratama%2CJ?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18404148 makes per month
- What's the financial intake of https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BD1cXltVGlurs%3D?
- How much does http://scholar.google.com/scholar_lookup?&title=Detection%2C%20clinical%20relevance%20and%20specific%20biological%20properties%20of%20disseminating%20tumour%20cells&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2375&volume=8&pages=329-340&publication_year=2008&author=Pantel%2CK&author=Brakenhoff%2CRH&author=Brandt%2CB pull in monthly?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19407470
- How profitable is https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:STN:280:DC%2BD1Mzlt1Kjtw%3D%3D?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Circulating%20and%20disseminated%20tumor%20cells%20in%20the%20clinical%20management%20of%20breast%20cancer%20patients%3A%20unanswered%20questions&journal=Oncology&doi=10.1159%2F000215581&volume=76&pages=375-386&publication_year=2009&author=Amadori%2CA&author=Rossi%2CE&author=Zamarchi%2CR&author=Carli%2CP&author=Pastorelli%2CD&author=Birillo%2CA?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16857794 each month?
- https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BD28XntFSms7Y%3D income
- How much does http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%20at%20each%20follow-up%20time%20point%20during%20therapy%20of%20metastatic%20breast%20cancer%20patients%20predict%20progression-free%20and%20overall%20survival&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-2821&volume=12&pages=4218-4224&publication_year=2006&author=Hayes%2CDF&author=Cristofanilli%2CM&author=Budd%2CGT&author=Ellis%2CMJ&author=Stopeck%2CA&author=Miller%2CMC&author=Matera%2CJ&author=Allard%2CWJ&author=Doyle%2CGV&author=Terstappen%2CLW make?
- How much profit does http://scholar.google.com/scholar_lookup?&title=What%20goes%20around%2C%20comes%20around%3A%20a%20review%20of%20circulating%20tumor%20cells&journal=MLO%20Med%20Lab%20Obs&volume=32&pages=34-36&publication_year=2010&author=Gage%2CT&author=Fan%2CSL generate?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20071161
- What's https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BC3cXhslWkt78%3D's gross income?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%3A%20a%20window%20into%20cancer%20biology%20and%20metastasis&journal=Curr%20Opin%20Genet%20Dev&doi=10.1016%2Fj.gde.2009.12.002&volume=20&pages=96-99&publication_year=2010&author=Maheswaran%2CS&author=Haber%2CDA is on a monthly basis
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19961486?
- Profit of https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BC3cXivFeqtrY%3D
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Epithelial-mesenchymal%20transition%20in%20cancer%20development%20and%20its%20clinical%20significance&journal=Cancer%20Sci&doi=10.1111%2Fj.1349-7006.2009.01419.x&volume=101&pages=293-299&publication_year=2010&author=Iwatsuki%2CM&author=Mimori%2CK&author=Yokobori%2CT&author=Ishi%2CH&author=Beppu%2CT&author=Nakamori%2CS&author=Baba%2CH&author=Mori%2CM is on a monthly basis
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17675394 pull in monthly?
- How much does https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:STN:280:DC%2BD2svlvVSkuw%3D%3D rake in every month?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Progress%20and%20promise%3A%20highlights%20of%20the%20international%20expert%20consensus%20on%20the%20primary%20therapy%20of%20early%20breast%20cancer%202007%20.10th%20St.%20Gallen%20conference&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdm271&volume=18&issue=7&pages=1133-1144&publication_year=2007&author=Goldhirsch%2CA&author=Wood%2CWC&author=Gelber%2CRD&author=Coates%2CAS&author=Th%C3%BCrlimann%2CB&author=Senn%2CHJ?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19821489
- Monthly income for https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BC3cXjvFahu74%3D
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Chemosensitivity%20profile%20assay%20of%20circulating%20cancer%20cells%3A%20prognostic%20and%20predictive%20value%20in%20epithelial%20tumors&journal=Int%20J%20Cancer&volume=126&issue=10&pages=2437-2447&publication_year=2010&author=Gazzaniga%2CP&author=Naso%2CG&author=Gradilone%2CA&author=Cortesi%2CE&author=Gandini%2CO&author=Gianni%2CW&author=Fabbri%2CMA&author=Vincenzi%2CB&author=di%20Silverio%2CF&author=Frati%2CL&author=Aglian%C3%B2%2CAM&author=Cristofanilli%2CM produce monthly?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8932346 generate?
- How much profit does https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:STN:280:DyaK2s%2Fos1KmtQ%3D%3D make?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20polypeptide%20expression%20in%20benign%20and%20malignant%20human%20breast%20lesions%3A%20down-regulation%20of%20cytokeratins&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.1996.600&volume=74&pages=1632-1638&publication_year=1996&author=Franzen%2CB&author=Linder%2CS&author=Alaiya%2CAA&author=Eriksson%2CE&author=Uruy%2CK&author=Hirano%2CT&author=Okuzawa%2CK&author=Auer%2CG
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11458120?
- Financial intake of https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:STN:280:DC%2BD3MvgsF2htg%3D%3D
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Disseminated%20cytokeratin%20positive%20tumor%20cells%20in%20the%20bone%20marrow%20of%20patients%20with%20prostate%20cancer%3A%20detection%20and%20prognostic%20value&journal=J%20Urol&doi=10.1016%2FS0022-5347%2805%2966046-6&volume=166&pages=699-703&publication_year=2001&author=Weckermann%2CD&author=Muller%2CP&author=Wawroschek%2CF&author=Harzmann%2CR&author=Riethm%C3%BCller%2CG&author=Schlimok%2CG?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14522883
- How much income is https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BD3sXnvVSjt7w%3D earning monthly?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Molecular%20signature%20associated%20with%20bone%20marrow%20micrometastasis%20in%20human%20breast%20cancer&journal=Cancer%20Res&volume=63&pages=5679-5684&publication_year=2003&author=Woelfle%2CU&author=Cloos%2CJ&author=Sauter%2CG&author=Riethdorf%2CL&author=J%C3%A4nicke%2CF&author=Diest%2CP&author=Brakenhoff%2CR&author=Pantel%2CK
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15102669 rake in every month?
- Learn about the earnings of https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BD2cXjt1Clt7Y%3D
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Downregulated%20expression%20of%20cytokeratin%2018%20promotes%20progression%20of%20human%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-03-0114&volume=10&pages=2670-2674&publication_year=2004&author=Woelfle%2CU&author=Sauter%2CG&author=Santjer%2CS&author=Braakenhoff%2CRH&author=Pantel%2CK
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16299229
- How much does https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BD2MXht1entr7K earn?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Changes%20in%20cytoskeletal%20protein%20composition%20indicative%20of%20an%20epithelial-mesenchymal%20transition%20in%20human%20micrometastatic%20and%20primary%20breast%20carcinoma%20cells&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-0632&volume=11&pages=8006-8014&publication_year=2005&author=Willipinski-Stapelfeldt%2CB&author=Riethdorf%2CS&author=Assmann%2CV&author=Woelfle%2CU&author=Rau%2CT&author=Sauter%2CG&author=Heukeshoven%2CJ&author=Pantel%2CK?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15567937 pull in?
- Profit of https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BD2cXmt1Kqt74%3D
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=High%20Ep-CAM%20expression%20is%20associated%20with%20poor%20prognosis%20in%20node-positive%20breast%20cancer&journal=Breast%20Cancer%20Res%20Treat&doi=10.1023%2FB%3ABREA.0000036787.59816.01&volume=86&pages=207-213&publication_year=2004&author=Spizzo%2CG&author=Went%2CP&author=Dirnhofer%2CS&author=Obrist%2CP&author=Simon%2CR&author=Spichtin%2CH&author=Maurer%2CR&author=Metzger%2CU&author=Castelberg%2CB&author=Bart%2CR&author=Stopatschinskaya%2CS&author=K%C3%B6chli%2COR&author=Haas%2CP&author=Mross%2CF&author=Zuber%2CM&author=Dietrich%2CH&author=Bischoff%2CS&author=Mirlacher%2CM&author=Sauter%2CG&author=Gastl%2CG?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20384575 net monthly?
- How much does https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtVWlsLbM generate monthly?
- How much income is http://scholar.google.com/scholar_lookup?&title=Cancer%20stem%20cells%20and%20epithelial-mesenchymal%20transition%3A%20revisiting%20minimal%20residual%20disease&journal=Curr%20Cancer%20Drug%20Targets&doi=10.2174%2F156800910791517154&volume=10&pages=496-508&publication_year=2010&author=Raimondi%2CC&author=Gianni%2CW&author=Cortesi%2CE&author=Gazzaniga%2CP earning monthly?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20303259?
- How much revenue does https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BC3cXkvFKqtrw%3D generate?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Cancer%20stemness%20and%20metastasis%3A%20therapeutic%20consequences%20and%20perspectives&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2010.02.030&volume=46&pages=1198-1203&publication_year=2010&author=Monteiro%2CJ&author=Fodde%2CR
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19584271?
- How much does https://link.springer.com/article/10.1007/s10549-011-1373-x/articles/cas-redirect/1:CAS:528:DC%2BD1MXosV2msrs%3D generate monthly?
- What's the income of http://scholar.google.com/scholar_lookup?&title=The%20emerging%20role%20of%20EpCAM%20in%20cancer%20and%20stem%20cell%20signaling&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-09-0654&volume=69&pages=5627-5629&publication_year=2009&author=Munz%2CM&author=Baeuerle%2CPA&author=Gires%2CO?
- How much revenue does https://citation-needed.springer.com/v2/references/10.1007/s10549-011-1373-x?format=refman&flavour=references produce monthly?
- Profit of https://link.springer.com/article/10.1007/s10549-011-1373-x/search?sortBy=newestFirst&dc.creator=Cristina%20Raimondi
- How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cristina%20Raimondi making per month?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cristina%20Raimondi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- How profitable is https://link.springer.com/article/10.1007/s10549-011-1373-x/search?sortBy=newestFirst&dc.creator=Angela%20Gradilone?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Angela%20Gradilone?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Angela%20Gradilone%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Monthly income for https://link.springer.com/article/10.1007/s10549-011-1373-x/search?sortBy=newestFirst&dc.creator=Giuseppe%20Naso
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Giuseppe%20Naso's earnings
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Giuseppe%20Naso%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Financial intake of https://link.springer.com/article/10.1007/s10549-011-1373-x/search?sortBy=newestFirst&dc.creator=Bruno%20Vincenzi
- Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Bruno%20Vincenzi
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Bruno%20Vincenzi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- How much profit does https://link.springer.com/article/10.1007/s10549-011-1373-x/search?sortBy=newestFirst&dc.creator=Arianna%20Petracca make?
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Arianna%20Petracca?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Arianna%20Petracca%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much income is https://link.springer.com/article/10.1007/s10549-011-1373-x/search?sortBy=newestFirst&dc.creator=Chiara%20Nicolazzo earning monthly?
- Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chiara%20Nicolazzo
- What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chiara%20Nicolazzo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://link.springer.com/article/10.1007/s10549-011-1373-x/search?sortBy=newestFirst&dc.creator=Antonella%20Palazzo rake in every month?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Antonella%20Palazzo generate?
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Antonella%20Palazzo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the profit of https://link.springer.com/article/10.1007/s10549-011-1373-x/search?sortBy=newestFirst&dc.creator=Rosa%20Saltarelli?
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rosa%20Saltarelli?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rosa%20Saltarelli%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Discover the revenue of https://link.springer.com/article/10.1007/s10549-011-1373-x/search?sortBy=newestFirst&dc.creator=Franco%20Spremberg
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Franco%20Spremberg income
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Franco%20Spremberg%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the revenue for https://link.springer.com/article/10.1007/s10549-011-1373-x/search?sortBy=newestFirst&dc.creator=Enrico%20Cortesi?
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Enrico%20Cortesi?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Enrico%20Cortesi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How profitable is https://link.springer.com/article/10.1007/s10549-011-1373-x/search?sortBy=newestFirst&dc.creator=Paola%20Gazzaniga?
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Paola%20Gazzaniga
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Paola%20Gazzaniga%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much revenue does https://link.springer.com/article/10.1007/s10549-011-1373-x/mailto:[email protected] produce monthly?
- What's the profit of https://static-content.springer.com/esm/art%3A10.1007%2Fs10549-011-1373-x/MediaObjects/10549_2011_1373_MOESM1_ESM.ppt?
- https://s100.copyright.com/AppDispatchServlet?title=Epithelial-mesenchymal%20transition%20and%20stemness%20features%20in%20circulating%20tumor%20cells%20from%20breast%20cancer%20patients&author=Cristina%20Raimondi%20et%20al&contentID=10.1007%2Fs10549-011-1373-x©right=Springer%20Science%2BBusiness%20Media%2C%20LLC.&publication=0167-6806&publicationDate=2011-02-05&publisherName=SpringerNature&orderBeanReset=true's total income per month
- Earnings of https://citation-needed.springer.com/v2/references/10.1007/s10549-011-1373-x?format=refman&flavour=citation
- What's https://link.springer.com/article/10.1007/s10549-011-1373-x/search?query=Circulating%20tumor%20cells&facet-discipline="Medicine%20%26%20Public%20Health"'s gross income?
- What's the financial outcome of https://link.springer.com/article/10.1007/s10549-011-1373-x/search?query=Epithelial-mesenchymal%20transition&facet-discipline="Medicine%20%26%20Public%20Health"?
- How much profit is https://link.springer.com/article/10.1007/s10549-011-1373-x/search?query=Cancer%20stem%20cells&facet-discipline="Medicine%20%26%20Public%20Health" making per month?
- How much income does https://link.springer.com/article/10.1007/s10549-011-1373-x/search?query=Cytokeratins&facet-discipline="Medicine%20%26%20Public%20Health" have?
- Check the income stats for https://link.springer.com/journals/a/1
- Find out how much https://link.springer.com/books/a/1 earns monthly
- Explore the financials of https://link.springer.com/journals
- What's https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's gross income?
- Explore the financials of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- What are the total earnings of https://www.springernature.com/gp/products?
- What's the income of https://www.springernature.com/gp/librarians?
- How profitable is https://www.springernature.com/gp/societies?
- What's the monthly income of https://www.springernature.com/gp/partners?
- Check the income stats for https://www.springer.com/
- What's the income generated by https://www.nature.com/ each month?
- How much does https://www.biomedcentral.com/ rake in every month?
- How much does https://www.palgrave.com/ bring in each month?
- What is the earnings of https://www.apress.com/?
- How much does https://link.springer.com/brands/discover earn?
- How much profit is https://www.springernature.com/gp/legal/ccpa making per month?
- https://www.springernature.com/gp/info/accessibility's total income per month
- What's the total monthly financial gain of https://link.springer.com/termsandconditions?
- https://support.springernature.com/en/support/home's total income per month
- How much does https://link.springer.com/legal-notice gross monthly?
- https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations income
- What are the earnings of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
Emails and Hosting {✉️}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {📦}
- Crossref